Appili Therapeutics Inc (APLI.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 3 | 4 | 3 | 4 | 3 |
| Accounts receivable | 314 | 1,156 | 89 | -1,009 | 1,038 |
| Other Working Capital | 327 | 1,067 | -201 | -833 | 722 |
| Other Operating Activity | -1,403 | -2,233 | 1,143 | 1,396 | -1,354 |
| Operating Cash Flow | $-759 | $-6 | $1,034 | $-442 | $409 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 0 | -1 | -2 |
| Investing Cash Flow | $0 | $0 | $0 | $-1 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -30 | -29 | -45 | -28 | -27 |
| Other Financing Activity | -47 | -13 | -16 | -13 | -16 |
| Financing Cash Flow | $-77 | $-42 | $-61 | $-41 | $-43 |
| Exchange Rate Effect | 60 | -55 | 69 | 5 | 0 |
| Beginning Cash Position | 1,125 | 1,228 | 186 | 665 | 301 |
| End Cash Position | 349 | 1,125 | 1,228 | 186 | 665 |
| Net Cash Flow | $-837 | $-49 | $973 | $-484 | $364 |
| Free Cash Flow | |||||
| Operating Cash Flow | -759 | -6 | 1,034 | -442 | 409 |
| Capital Expenditure | N/A | N/A | N/A | -1 | N/A |
| Free Cash Flow | -759 | -6 | 1,034 | -443 | 409 |